Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis. (2019)

First Author: Brown JWL
Attributed to:  MRC Centre for Neuropsychiatric Genetics and Genomics funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1001/jama.2018.20588

PubMed Identifier: 30644981

Publication URI: http://europepmc.org/abstract/MED/30644981

Type: Journal Article/Review

Volume: 321

Parent Publication: JAMA

Issue: 2

ISSN: 0098-7484